Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $66.2 million.

  • Nuvation Bio's Operating Expenses rose 3992.98% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.5 million, marking a year-over-year decrease of 5571.32%. This contributed to the annual value of $593.4 million for FY2024, which is 49448.02% up from last year.
  • As of Q3 2025, Nuvation Bio's Operating Expenses stood at $66.2 million, which was up 3992.98% from $65.8 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Operating Expenses ranged from a high of $470.5 million in Q2 2024 and a low of $20.2 million during Q1 2024
  • For the 3-year period, Nuvation Bio's Operating Expenses averaged around $80.5 million, with its median value being $47.3 million (2024).
  • Per our database at Business Quant, Nuvation Bio's Operating Expenses surged by 170044.01% in 2024 and then plummeted by 8600.43% in 2025.
  • Quarter analysis of 3 years shows Nuvation Bio's Operating Expenses stood at $20.8 million in 2023, then soared by 166.13% to $55.4 million in 2024, then grew by 19.42% to $66.2 million in 2025.
  • Its last three reported values are $66.2 million in Q3 2025, $65.8 million for Q2 2025, and $60.0 million during Q1 2025.